PP131 – Macrophages in lung adenocarcinoma

Giannoula Ntaliarda, Greece

Source: ERS Lung Science Conference 2021
Number: 63

E-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giannoula Ntaliarda, Greece. PP131 – Macrophages in lung adenocarcinoma. ERS Lung Science Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Splenic metastasis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Carcionoid tumors of the lung
Source: Eur Respir J 2002; 20: Suppl. 38, 457s
Year: 2002

LSC - 2021 - Macrophages in lung adenocarcinoma
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10
Source: Eur Respir J 2007; 30: 608-610
Year: 2007


Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008


Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007

Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008


Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017

Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



Subtypes of lung adenocarcinomas associated with IPF
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016

Tumor markers in bronchial secretions and serum in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 76s
Year: 2004

Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Neuroendocrine tumours of the lung other than SCLC
Source: ERS webinar 2021: Neuroendocrine tumours of the lung other than SCLC
Year: 2021


Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Nonsmall cell lung cancer
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012


Stem cells and lung cancer
Source: Eur Respir Monogr 2021; 91: 340-352
Year: 2021


Synchronous primary lung cancer with three separate tumors
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007